Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Secondary Mitral Regurgitation: Diagnosis and Management
Author(s): Nehal Dhaduk , Adib Chaus , David Williams , et al Added: 1 month ago

Imaging & Diagnostics

Intervention
Optimising Treatment of HF
Author(s): Shelley Zieroth , Martin R Cowie , Javed Butler , et al Added: 2 years ago
Following recent changes to guidelines in light ofthe publication of Phase III data with SGLT2 inhibitors in patients with HFrEF, with and without type 2 diabetes, this programme brings together a leading faculty to best inform of the latest clinical evidence and real-world application for optimising treatment strategies in heart failure. Prof Martin Cowie (Imperial College London, UK),… View more

Heart Failure
HF 22: 2022 Heart Failure Highlights with Dr Kosiborod
Author(s): Mikhail Kosiborod Added: 1 year ago
In this short video we asked Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) about the key heart failure highlights of 2022 and his thoughts on what comes next in HF treatment and research. Recorded at Heart Failure 2022, Madrid. View more

Heart Failure
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
ACC 23 Late-breaker Discussion: The REVIVED-BCIS2 Viability Study
Author(s): Harriette Van Spall , Divaka Perera , Peter O’Kane Added: 1 year ago
ACC.23/WCC — Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by principle investigator, Dr Divaka Perera (King’s College London & Guy’s & St Thomas’ Hospital, UK) and investigator, Dr Peter O'Kane (Royal Bournemouth Hospital, UK) to discuss the REVIVED-BCIS2 viability analysis (NCT01920048). This analysis of the REVIVED-BICS2 trial found that viability… View more

Imaging & Diagnostics

Heart Failure
ESC 22: 3 Trials That Will Change Your Practice With Dr Martha Gulati
Author(s): Martha Gulati Added: 1 year ago
ESC Congress 2022 — In this short and practice-focused review, Dr Martha Gulati, Associate Director of the Barbra Streisand Women Heart Center and Director of CVD Prevention(Cedars-Sinai Medical Center, US) shares some her thoughts on the top 3 hot line trials. Trials covered in detail include: 00:27: TIME:The Treatment in Morning versus Evening 01:57: SECURE:A polypill strategy in secondary… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure
Author(s): Stephen J Greene Added: 10 months ago
ESC-HFA 23 — Dr Stephen Greene (Duke University School of Medicine, US) outlines the findings from the QoL study of the TRANSFORM-HF Trial (NCT03296813). The TRANSFORM-HF trial is a randomized trial which compared torsemide to furosemide as a treatment for patients with heart failure. Around 2859 patients with heart failure were enrolled in the trial, whose clinical outcomes were measured across… View more

Heart Failure
ACC 21: 30-day Results of the TRISCEND Study
Author(s): Susheel Kodali Added: 2 years ago
In this interview, Dr Susheel Kodali (Columbia University Medical Center, New York, US) discusses the 30-day results of the TRISCEND trial. He details the key findings of the study so far, and the next steps to be taken.Thismulti-centre, prospective, single-arm study evaluates the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System Questions:
 1.What is the TRISCEND… View more

Intervention
Author(s): Steven R Sigman Added: 3 years ago
Although less common than other forms of cardiomyopathy, cardiac sarcoidosis (CS), both as part of a systemic process and in its isolated form, is an important, and increasingly recognized disorder. This is felt to be due, in part, to advances in cardiac imaging and heightened awareness of the disorder.1,2 CS is associated with high rates of morbidity and mortality, including sudden cardiac death… View more

Imaging & Diagnostics
Author(s): Mehmet Ali Elbey , Luis Augusto Palma Dallan , Guilherme Ferragut Attizzani Added: 3 years ago
The field of mitral valve disease diagnosis and management is in constant change. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities have led to more complex treatments. Transcatheter mitral valve repair with a MitraClip device is resulting in good outcomes in patients with primary mitral regurgitation who are at high… View more

Vascular Disease and Surgery

Intervention